Insulin Glargine Combination Therapies in Type II Diabetics
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To compare efficacy of combination therapy of insulin glargine plus glimepiride and metformin
versus 2 injections insulin monotherapy with premixed insulin NPH 30/70 bid in terms of
change of HbA1c (baseline to endpoint) to show non-inferiority of insulin glargine plus
glimepiride and metformin.